Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases

Overview

Journal ACS Cent Sci

Specialty Chemistry

Date 2020 Apr 1

PMID 32226821

Citations 582

Authors

Cynthia Liu

Qiongqiong Zhou

Yingzhu Li

Linda V Garner

Steve P Watkins

Linda J Carter

Jeffrey Smoot

Anne C Gregg

Angela D Daniels

Susan Jervey

Dana Albaiu

Affiliations

Soon will be listed here.

Citing Articles

Affinity Tag-Free Purification of SARS-CoV-2 N Protein and Its Crystal Structure in Complex with ssDNA.

Maiti A, Matsuo H Biomolecules. 2025; 14(12.

PMID: 39766245 PMC: 11673995. DOI: 10.3390/biom14121538.

A Systematic Review of the Attitudes, Beliefs, and Acceptance of the COVID-19 Vaccine in the Western and Eastern Hemispheres.

Sorath F, Shiwlani S, Sindhu F, Lohana A, Mohammed Y, Chander S Cureus. 2024; 16(11):e73161.

PMID: 39650886 PMC: 11624041. DOI: 10.7759/cureus.73161.

Design, Synthesis, Biological Evaluation and Molecular Docking Studies of New Thiazolidinone Derivatives as NNRTIs and SARS-CoV-2 Main Protease Inhibitors.

Fesatidou M, Petrou A, Geronikaki A Chem Biodivers. 2024; 21(12):e202401697.

PMID: 39442074 PMC: 11644116. DOI: 10.1002/cbdv.202401697.

In Silico Evaluation of HIV Protease and RNA Polymerase Inhibitors as Potential COVID-19 Therapeutics.

Devaraji M, Ravikumar L Cureus. 2024; 16(9):e69576.

PMID: 39421085 PMC: 11483341. DOI: 10.7759/cureus.69576.

Exploration of Specific Fluoroquinolone Interaction with SARS-CoV-2 Main Protease (Mpro) to Battle COVID-19: DFT, Molecular Docking, ADME and Cardiotoxicity Studies.

Khan M, Mutahir S, Tariq M, Almehizia A Molecules. 2024; 29(19).

PMID: 39407649 PMC: 11477632. DOI: 10.3390/molecules29194721.

References

Kumar V, Shin J, Shie J, Ku K, Kim C, Go Y . Identification and evaluation of potent Middle East respiratory syndrome coronavirus (MERS-CoV) 3CL inhibitors. Antiviral Res. 2017; 141:101-106. PMC: 7113684. DOI: 10.1016/j.antiviral.2017.02.007. View

Tang B, Bragazzi N, Li Q, Tang S, Xiao Y, Wu J . An updated estimation of the risk of transmission of the novel coronavirus (2019-nCov). Infect Dis Model. 2020; 5:248-255. PMC: 7029158. DOI: 10.1016/j.idm.2020.02.001. View

Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M . Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020; 30(3):269-271. PMC: 7054408. DOI: 10.1038/s41422-020-0282-0. View

Maxmen A . More than 80 clinical trials launch to test coronavirus treatments. Nature. 2020; 578(7795):347-348. DOI: 10.1038/d41586-020-00444-3. View

Zeldin R, Petruschke R . Pharmacological and therapeutic properties of ritonavir-boosted protease inhibitor therapy in HIV-infected patients. J Antimicrob Chemother. 2003; 53(1):4-9. DOI: 10.1093/jac/dkh029. View

Li G, De Clercq E . Therapeutic options for the 2019 novel coronavirus (2019-nCoV). Nat Rev Drug Discov. 2020; 19(3):149-150. DOI: 10.1038/d41573-020-00016-0. View

. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020; 5(4):536-544. PMC: 7095448. DOI: 10.1038/s41564-020-0695-z. View

Modjarrad K, Roberts C, Mills K, Castellano A, Paolino K, Muthumani K . Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial. Lancet Infect Dis. 2019; 19(9):1013-1022. PMC: 7185789. DOI: 10.1016/S1473-3099(19)30266-X. View

Tipnis S, Hooper N, Hyde R, Karran E, Christie G, Turner A . A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem. 2000; 275(43):33238-43. DOI: 10.1074/jbc.M002615200. View

10.

Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S . SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020; 181(2):271-280.e8. PMC: 7102627. DOI: 10.1016/j.cell.2020.02.052. View

11.

Yang Z, Huang Y, Ganesh L, Leung K, Kong W, Schwartz O . pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN. J Virol. 2004; 78(11):5642-50. PMC: 415834. DOI: 10.1128/JVI.78.11.5642-5650.2004. View

12.

Wrapp D, Wang N, Corbett K, Goldsmith J, Hsieh C, Abiona O . Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020; 367(6483):1260-1263. PMC: 7164637. DOI: 10.1126/science.abb2507. View

13.

Yan B, Wang H, Tan Y, Fu W . microRNAs in Cardiovascular Disease: Small Molecules but Big Roles. Curr Top Med Chem. 2019; 19(21):1918-1947. DOI: 10.2174/1568026619666190808160241. View

14.

Lu R, Zhao X, Li J, Niu P, Yang B, Wu H . Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020; 395(10224):565-574. PMC: 7159086. DOI: 10.1016/S0140-6736(20)30251-8. View

15.

Chan J, Kok K, Zhu Z, Chu H, To K, Yuan S . Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect. 2020; 9(1):221-236. PMC: 7067204. DOI: 10.1080/22221751.2020.1719902. View

16.

Zhu N, Zhang D, Wang W, Li X, Yang B, Song J . A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020; 382(8):727-733. PMC: 7092803. DOI: 10.1056/NEJMoa2001017. View

17.

Du L, He Y, Zhou Y, Liu S, Zheng B, Jiang S . The spike protein of SARS-CoV--a target for vaccine and therapeutic development. Nat Rev Microbiol. 2009; 7(3):226-36. PMC: 2750777. DOI: 10.1038/nrmicro2090. View

18.

Richardson P, Griffin I, Tucker C, Smith D, Oechsle O, Phelan A . Baricitinib as potential treatment for 2019-nCoV acute respiratory disease. Lancet. 2020; 395(10223):e30-e31. PMC: 7137985. DOI: 10.1016/S0140-6736(20)30304-4. View

19.

Baez-Santos Y, St John S, Mesecar A . The SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds. Antiviral Res. 2015; 115:21-38. PMC: 5896749. DOI: 10.1016/j.antiviral.2014.12.015. View

20.

Ziebuhr J, Snijder E, Gorbalenya A . Virus-encoded proteinases and proteolytic processing in the Nidovirales. J Gen Virol. 2000; 81(Pt 4):853-79. DOI: 10.1099/0022-1317-81-4-853. View